Recommendations for the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia

Autor: Jacobson, B. F., Schapkaitz, E., Mer, M., Louw, S., Haas, S., Buller, H. R., Brenner, B., Abdool-Carrim, A. T. O., de Jong, P., Hsu, P., Jankelow, D., Lebos, M., Levy, B., Radford, H., Rowji, P., Redman, L., Sussman, M., van der Jagt, D., Wessels, P. F., Williams, P. G.
Přispěvatelé: Vascular Medicine, ACS - Pulmonary hypertension & thrombosis
Jazyk: angličtina
Rok vydání: 2021
Zdroj: South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 111(6), 535-537. South African Medical Association
ISSN: 0256-9574
Popis: There have recently been safety concerns regarding an increased risk of vaccine-induced immune thrombotic thrombocytopenia (VITT) following administration of SARS-CoV-2 adenoviral vector vaccines. The Southern African Society of Thrombosis and Haemostasis reviewed the emerging literature on this idiosyncratic complication. A draft document was produced and revised by consensus agreement by a panel of professionals from various specialties. The recommendations were adjudicated by independent international experts to avoid local bias. We present concise, practical guidelines for the clinical management of VITT.
Databáze: OpenAIRE